Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Tremmel

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Age and Ageing|January 25, 2022
Mobility endpoints in marketing authorisation of drugs: what gets the European medicines agency moving?Simon U Jaeger, Martin Wohlrab, Daniel Schoene, et al.
Archives of Toxicology|August 13, 2024
Metabolic activation of WHO-congeners PCB28, 52, and 101 by human CYP2A6: evidence from in vitro and in vivo experimentsIsabella Randerath, Thomas Schettgen, Julian Peter Müller, et al.
Archives of Toxicology|August 15, 2025
Polychlorinated biphenyls (PCBs) interact with drug metabolism in vivoJulian Peter Müller, Jens Rengelshausen, Salah Laieb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2025
Supplementation of Tamoxifen with Low-Dose Endoxifen in Patients with Breast Cancer with Impaired Tamoxifen Metabolism (TAMENDOX): A Randomized Controlled Phase I/II TrialThomas E Mürdter, Werner Schroth, Matthew P Goetz, et al.
International Journal of Molecular Sciences|July 9, 2022
Hepatic Expression of the Na<sup>+</sup>-Taurocholate Cotransporting Polypeptide Is Independent from Genetic VariationRoman Tremmel, Anne T Nies, Barbara A C van Eijck, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 2, 2024
Consequences of Amyloid-β Deficiency for the LiverGayane Hrachia Buniatian, Ute Schwinghammer, Roman Tremmel, et al.
Cells|February 25, 2020
Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic LiverGayane Hrachia Buniatian, Ralf Weiskirchen, Thomas S Weiss, et al.
Clinical Pharmacology and Therapeutics|January 11, 2023
Cross-Ancestry Genome-Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma ConcentrationsChiea Chuen Khor, Stefan Winter, Natalia Sutiman, et al.
Clinical Pharmacology and Therapeutics|June 24, 2025
Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE StudyHenk-Jan Guchelaar, Cathelijne H van der Wouden, Lisanne E N Manson, et al.
Lancet (London, England)|February 4, 2023
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation studyJesse J Swen, Cathelijne H van der Wouden, Lisanne En Manson, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Age and Ageing|January 25, 2022
Mobility endpoints in marketing authorisation of drugs: what gets the European medicines agency moving?Simon U Jaeger, Martin Wohlrab, Daniel Schoene, et al.
Archives of Toxicology|August 13, 2024
Metabolic activation of WHO-congeners PCB28, 52, and 101 by human CYP2A6: evidence from in vitro and in vivo experimentsIsabella Randerath, Thomas Schettgen, Julian Peter Müller, et al.
Archives of Toxicology|August 15, 2025
Polychlorinated biphenyls (PCBs) interact with drug metabolism in vivoJulian Peter Müller, Jens Rengelshausen, Salah Laieb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2025
Supplementation of Tamoxifen with Low-Dose Endoxifen in Patients with Breast Cancer with Impaired Tamoxifen Metabolism (TAMENDOX): A Randomized Controlled Phase I/II TrialThomas E Mürdter, Werner Schroth, Matthew P Goetz, et al.
International Journal of Molecular Sciences|July 9, 2022
Hepatic Expression of the Na<sup>+</sup>-Taurocholate Cotransporting Polypeptide Is Independent from Genetic VariationRoman Tremmel, Anne T Nies, Barbara A C van Eijck, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 2, 2024
Consequences of Amyloid-β Deficiency for the LiverGayane Hrachia Buniatian, Ute Schwinghammer, Roman Tremmel, et al.
Cells|February 25, 2020
Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic LiverGayane Hrachia Buniatian, Ralf Weiskirchen, Thomas S Weiss, et al.
Clinical Pharmacology and Therapeutics|January 11, 2023
Cross-Ancestry Genome-Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma ConcentrationsChiea Chuen Khor, Stefan Winter, Natalia Sutiman, et al.
Clinical Pharmacology and Therapeutics|June 24, 2025
Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE StudyHenk-Jan Guchelaar, Cathelijne H van der Wouden, Lisanne E N Manson, et al.
Lancet (London, England)|February 4, 2023
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation studyJesse J Swen, Cathelijne H van der Wouden, Lisanne En Manson, et al.
Pageof 5